Chairman Phillip Frost

Billionaire Phillip Frost, chairman of Teva Pharmaceutical Industries Ltd., stands for portrait in Miami, Florida, U.S., on Thursday Dec. 6, 2012. TevaÕs stock is undervalued and investors will realize that as Levin implements a new strategy, said Frost, who became a Teva shareholder when he sold his generic-drug maker Ivax Corp. to Teva for $7.6 billion in 2006. Photographer: Emiliano Granado/Bloomberg